Stephen Taub

1 month ago | institutionalinvestor.com | Stephen Taub

The AI chip giant’s first-quarter earnings vindicate a slew of managers who bet the Nvidia trade was far from dead and piled into its stock.

1 month ago | institutionalinvestor.com | Stephen Taub

Despite Turmoil, Hedge Funds Mostly Stood Pat on Their Favorite StocksJust one new stock cracked the top-20 ranking as of the end of the first quarter.

1 month ago | institutionalinvestor.com | Stephen Taub |IFM Investors

Several hedge funds are gearing up for a rare and much-anticipated initial public offering this week. Hinge Health plans to sell 13.7 million shares for between $28 and $32 apiece. The total includes about 8.5 million shares from the company and more than 5.1 million from shareholders selling stakes, according to a regulatory filing. The company expects to raise about $437 million and be valued at nearly $2.98 billion.

1 month ago | institutionalinvestor.com | Stephen Taub

Skye Global cut its largest long position nearly in half in the first quarter, a big move for the concentrated hedge fund headed by Jamie Sterne. Sterne traditionally runs a portfolio where one or two stocks account for the bulk of assets. So it was striking when Sterne reported in his first-quarter 13F that he’d sold more than five million shares of Amazon, or 45 percent of the total position.

1 month ago | institutionalinvestor.com | Stephen Taub |IFM Investors

Two of the highest-profile hedge fund firms have shuffled their biggest bets. But, according to their first-quarter stock holdings reports, Bridgewater Associates made major changes to its portfolio, while Renaissance Technologies more or less tinkered. Bridgewater pared its largest long position by more than half, initiated one new position, and more than doubled other significant holdings.